Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients

AIM: To explore whether olanzapine alters bone mineral density (BMD), glucose, and lipid metabolism in schizophrenia patients. METHODS: This study enrolled 150 patients diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), including 101 patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Mining, Zhang, Beibei, Deng, Lu, Xu, Rong, Wu, Haishan, Chen, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451798/
https://www.ncbi.nlm.nih.gov/pubmed/31019532
http://dx.doi.org/10.1155/2019/1312804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451798/
https://www.ncbi.nlm.nih.gov/pubmed/31019532
http://dx.doi.org/10.1155/2019/1312804

Ejemplares similares